130 related articles for article (PubMed ID: 20031680)
1. Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery.
Reddy MK; Vasir JK; Sahoo SK; Jain TK; Yallapu MM; Labhasetwar V
Circ Cardiovasc Interv; 2008 Dec; 1(3):209-16. PubMed ID: 20031680
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin induces excessive neointima formation: a study in a rat carotid artery model of vascular injury.
Reddy MK; Vasir JK; Hegde GV; Joshi SS; Labhasetwar V
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):237-47. PubMed ID: 17875952
[TBL] [Abstract][Full Text] [Related]
3. Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats.
Uwatoku T; Shimokawa H; Abe K; Matsumoto Y; Hattori T; Oi K; Matsuda T; Kataoka K; Takeshita A
Circ Res; 2003 Apr; 92(7):e62-9. PubMed ID: 12663484
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
Park SJ; Kim HS; Yang HM; Park KW; Youn SW; Jeon SI; Kim DH; Koo BK; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):885-91. PubMed ID: 14988093
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
Parry TJ; Brosius R; Thyagarajan R; Carter D; Argentieri D; Falotico R; Siekierka J
Eur J Pharmacol; 2005 Nov; 524(1-3):19-29. PubMed ID: 16271360
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by inhibition of cyclic AMP response element-binding protein in vascular smooth muscle cells.
Tokunou T; Shibata R; Kai H; Ichiki T; Morisaki T; Fukuyama K; Ono H; Iino N; Masuda S; Shimokawa H; Egashira K; Imaizumi T; Takeshita A
Circulation; 2003 Sep; 108(10):1246-52. PubMed ID: 12939230
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
8. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
10. [Local applied slow-releasing rapamycin inhibits neointima hyperplasia in vein graft].
Zhang LF; Xiao F; Li J; Wang J; Shi ZH; Li CY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1706-9. PubMed ID: 16854327
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia.
Aizawa Y; Kawabe J; Hasebe N; Takehara N; Kikuchi K
Circulation; 2001 Jul; 104(4):455-60. PubMed ID: 11468209
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
13. Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia.
Statius van Eps RG; ChandraSekar NR; Hasan T; LaMuraglia GM
Photochem Photobiol; 1998 Mar; 67(3):337-42. PubMed ID: 9523533
[TBL] [Abstract][Full Text] [Related]
14. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of thalidomide and tamoxifen in preventing neointimal hyperplasia in experimental vascular injury in rats.
Santana AC; Marinotto DB; Dellê H; Cordeiro AC; Noronha IL
Transplant Proc; 2010 Mar; 42(2):585-8. PubMed ID: 20304198
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Mst1 in vascular remodeling after injury.
Ono H; Ichiki T; Ohtsubo H; Fukuyama K; Imayama I; Hashiguchi Y; Sadoshima J; Sunagawa K
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1871-6. PubMed ID: 15961701
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin gene transfer induces neointimal apoptosis and inhibits neointimal hyperplasia in injured rat artery.
Rauma-Pinola T; Pääkkö P; Ilves M; Serpi R; Romppanen H; Vuolteenaho O; Ruskoaho H; Hautala T
J Gene Med; 2006 Apr; 8(4):452-8. PubMed ID: 16389603
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T
Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery.
Kitada K; Yui N; Matsumoto C; Mori T; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2009 Dec; 331(3):998-1004. PubMed ID: 19737855
[TBL] [Abstract][Full Text] [Related]
20. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model.
Hayashi K; Nakamura S; Morishita R; Moriguchi A; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Sakai N; Ogihara T
Gene Ther; 2000 Oct; 7(19):1664-71. PubMed ID: 11083475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
